Nan Qin
CEO of Shanghai Realbio Technology Co. LTD

Research Fellow of the Tenth People's Hospital of Tongji University, Doctoral Supervisor, the winner of the First Prize of Shanghai Science and Technology Progress Award, expert of Shanghai Program for Overseas High-level Talents Introduction, member of the Youth Committee of Tumor Marker Committee of Chinese Anti-Cancer Association, an editorial board member of Chinese Journal of Microecology, and the winner of the Second Shulan Medical Youth Award and "Great Challenge Young Scientist" Award issued by the Ministry of Science and Technology and Gates Foundation.
2008-2011: Person in charge of Microbial Genome Department of the Beijing Genomics Institute (BGI); 2011-2016: Special Research Fellow of the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases of the First Affiliated Hospital, Zhejiang University Doctor in Microbiology of Virginia Polytechnic Institute (United States), EMBA of China Europe International Business School
The current research areas include the infectious disease, metabolic disease, autoimmune disease and the relationship between the tumor immunotherapy and infectious diseases. The long-term goal of these researches is to develop new technology concerned with human health for early screening and diagnosis of tumors.
Since 2009, he has presided over or participated in many national and ministerial and provincial-level scientific research projects and talent program projects, and has published more than 50 papers in top international academic journals such as Nature and Science.

Copyright Shanghai Realbio Technology (RBT) Co., Ltd., 沪ICP备16022951号

沪公网安备 31011202006680号